Reyes et al. conducted a qualitative study with women carrying a CHEK2 or ATM pathogenic variant and focused on this very special experience of uncertainty regarding specific cancer risk estimates and regarding the effectiveness of certain risk management strategies [22]. This evidence concerns the gene CHEK2 and cancer.